Number of shares and votes in Active Biotech
The number of shares and votes in Active Biotech has changed as a result of the
exercise of employee stock options and the private placement with international
institutional investors and qualified investors in Sweden.
Today, the last trading day of the month, there are in total 68,582,691 shares
and votes in Active Biotech.
Lund, February 28, 2011
Active Biotech AB (publ)
For further information, please contact:
Hans Kolam, CFO
Tel: +46 (0)46 19 20 44
About Active Biotech
Active Biotech AB (NASDAQ OMX NORDIC: ACTI) is a biotechnology company with
focus on autoimmune/inflammatory diseases and cancer. Projects in or entering
pivotal phase are laquinimod, an orally administered small molecule with unique
immunomodulatory properties for the treatment of multiple sclerosis, TASQ for
prostate cancer and ANYARA for use in cancer targeted therapy, primarily of
renal cell cancer. In addition, laquinimod is in Phase II development for
Crohn's and Lupus. Further projects in clinical development comprise the two
orally administered compounds, 57- 57 for SLE and Systemic Sclerosis as well as
RhuDex(TM) for RA. Please visit www.activebiotech.com for more information.
Active Biotech AB
PO Box 724, SE-220 07 Lund
Tel: +46 (0)46-19 20 00
Fax: +46 (0)46-19 11 00
Active Biotech is required under the Securities Markets Act to make the
information in this press release public. The information was submitted for
publication at 10:30 am CET on February 28, 2011.
Number of shares and votes in Active Biotech:
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Active Biotech via Thomson Reuters ONE